Cibus Q3 net loss narrows 10% to $21.94 million
CBUS•Cibus’ third-quarter 2026 net loss narrowed 10% year over year to $21.94 million, while revenue rose 30% to $800,000. Cash was $10.7 million at September 30, which the company said would fund planned operations and capital expenditures into early first-quarter 2027.
1. Quarterly results and cash
Cibus reported third-quarter 2026 revenue of $800,000, up 30% year over year, and a net loss of $21.94 million, down 10%. Nine-month operating cash usage fell approximately 19% year over year to $30.2 million; the company’s targeted year-end annualized net cash usage remains approximately $35 million. Cash totaled $10.7 million at September 30, sufficient to fund planned operations and capital expenditures into early first-quarter 2027.
2. Product development
Rice herbicide-tolerance traits advanced into testing in Interoc’s own varieties, with results expected in first-quarter 2027. Manufacturing began for initial biofragrance production runs; the eight-ingredient portfolio could generate approximately $100 million in peak annual revenue.
